Share:
Chromadex Corp (NASDAQ: CDXC) shares jumped 111% in the regular and after-hours sessions today.
What Happened: The price movement on Thursday was accompanied by intense trading with volumes of 116.67 million. The average volume for ChromaDex shares is 523,511.
While there were no immediate triggers for share movement on Thursday, the bioscience company announced results from a Phase 3 study that examined its nutritional protocol in the treatment of COVID-19, a day prior.
“The nutritional protocol significantly improves the recovery, liver health, and markers of inflammation of patients with COVID-19,” said Adil Mardinoglu, a professor at King’s College London, as per a company statement.